	Recent Publications 2005 Publications 2004 Publications 2003 Publications 1985 – 2002 Publications

Publications Archive

1985 – 2002 Publications

Barton JJS, Cherkasova MV, Lindgren K, Goff DC, Intriligator J, Manoach DS. Antisaccades and task-shifting: studies of control processes in saccadic function in normal subjects and schizophrenia. Annals of the New York Academy of Sciences 2002; 956:250-263. View Abstract

Goff DC, Hennen J, Tsai G, Evins AE, Yurgelun-Todd D, Renshaw P. Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to clozapine. Biological Psychiatry 2002;51:493-497. View Abstract

Heckers S, Goff DC, Weiss AP. Reversed hemispheric asymmetry during simple visual perception in schizophrenia. Psychiatry Research 2002;116:25-32. View Abstract

Kuperberg GR, Kerwin R, Murray RM. Developments in the pharmacological treatment of schizophrenia. Expert Opinion on Investigational Drugs. 2002;11:1335-1341. View Abstract

Manoach DS, Lindgren K, Cherkasova MV, Goff DC, Halpern EF, Intriligator J,Barton JJS. Schizophrenic subjects show deficient inhibition but intact task-switching on saccadic tasks. Biological Psychiatry 2002;51:816-825. View Abstract

Pascual-Leone A, Manoach DS, Birnbaum R, Goff DC. Motor cortical excitability in schizophrenia. Biological Psychiatry 2002;52:24-31. View Abstract

Stinikova T, Salisbury DF, Kuperberg G, Holcomb PJ. Electrophysiological insights into language processing in schizophrenia. Psychophysiology. 2002;39:851-860. View Abstract

Weiss AP, Dodson CS, Goff DC, Schacter DL, Heckers S. Intact suppression of increased false recognition in schizophrenia. American Journal of Psychiatry 2002;159:1506-1513. View Abstract

Evins AE, Mays V, Rigotti N, Tisdale T, Daigle A, Goff DC. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine and Tobacco Research 2001;3:397-403. View Abstract

Frankle WG, Shera D, Berger-Hershkowitz H, Evins EA, Connolly C, Henderson DC, Goff DC. Clozapine associated reduction in arrest rates. American Journal of Psychiatry 2001; 158:270-274. View Abstract

Goff DC, Leahy L, Berman I, Posever T, Herz L, Leon AC, Johnson SA. A Placebo-Controlled Pilot Study of the Ampakine, CX516, Added to Clozapine in Schizophrenia. J Clinical Psychopharmacology 2001;21:484-487. View Abstract

Gould RA, Mueser KT, Bolton E, Mays V, Goff DC. Cognitive therapy for psychosis in schizophrenia: An effect size analysis. Schizophrenia Research 2001;48: 335-342. View Abstract

Henderson DC, Goff DC, Connolly CE, Borba CP, Hayden D. Risperidone added to clozapine: Impact on serum prolactin levels. Journal of Clinical Psychiatry 2001; 62: 605-608.
View Abstract

Manoach, DS, Halpern EF, Kramer TS, Chang Y, Goff DC, Rauch SL, Kennedy DN, Gollub RL. Test-retest reliability of a functional MRI working memory paradigm in normal and schizophrenic subjects. American Journal of Psychiatry 2001;158:955-957. View Abstract

Evins AE, Fitzgerald S, Wine L, Rosselli R, Goff DC. A placebo controlled trial of glycine added to clozapine in schizophrenia. American Journal of Psychiatry 2000;157:826-828. View Abstract

Heckers S, Curran T, Goff D, Rauch SL, Fischman AJ, Alpert NM, Schacter DL. Abnormalities in the thalamus and prefrontal cortex during episodic object recognition in schizophrenia. Biological Psychiatry 2000;48:651-657. View Abstract

Henderson DC, Cagliero E, Gray C, Nasrallah RA, Hayden DL, Schoenfeld DA, Goff DC: Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five year naturalistic study. Am J Psychiatry 2000;157:975-981 View Abstract

Hoffman SG, Bufka LF, Brady SM, DuRand C, Goff DC. Cognitive-behavioral treatment of panic in patients with schizophrenia: Preliminary findings. Journal of Cognitive Psychotherapy 2000;14:381-392.

Kearns A, Goff DC, Hayden D, Daniels G. Risperidone-Associated Hyperprolactinemia. Endocrine Practice. 2000; 6:425-429. View Abstract

Kuperberg GR, McGuire PK, Bullmore ET, Brammer MJ, Rabe-Hesketh S, Wright IC, Lythgoe DJ, Williams SC, David AS. Common and distinct neural substrates for pragmatic, semantic, and syntactic processing of spoken sentences: an fMRI study. Journal of Cognitive Neuroscience. 2000;12: 321-341. View Abstract

Kuperberg GR, McGuire PK, David AS. Sensitivity to linguistic anomalies in spoken sentences: a case study approach to understanding thought disorder in schizophrenia. Psychological Medicine. 2000; 30:345-357. View Abstract

Manoach DS, Gollub RL, Benson ES, Searl MM, Goff DC, Halpern E, Saper CB, Rauch SL. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biological Psychiatry 2000;48:99-109. View Abstract

Goff DC, Henderson DC, Evins AE, Amico E. A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia. Biological Psychiatry 1999;45:512-514. View Abstract

Goff DC, Tsai G, Levitt J, Amico E, Manoach D, Schoenfeld DA, Hayden DL, McCarley R, Coyle JT. A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Archives of General Psychiatry 1999;56: 21-27. View Abstract

Heckers S, Goff D, Schacter DL, Savage CR, Fischman AJ, Alpert NM, Rauch SL. Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia. Archives of General Psychiatry 1999;56:1117-23. View Abstract

Manoach DS, Press DZ, Thangaraj V, Searl MM, Goff DC, Halpern E, Saper CB, Warach S. Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biological Psychiatry 1999;45:1128-1137. View Abstract

Goff DC, Posever T, Herz L, Simmons J, Kletti N, Lapierre K, Wilner KD, Law CG, Ko GN. An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder. Journal of Clinical Psychopharmacology 1998;18:296-304. View Abstract

Heckers S, Rauch SL, Goff D, Savage CR, Schacter DL, Fishman AJ, Alpert NM. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nature Neuroscience 1998;1:318-323. View Abstract

Henderson DC, Nasrallah RA, Goff DC. Switching from clozapine to olanzapine in treatment-refractory schizophrenia: safety, clinical efficacy, and predictors of response. Journal of Clinical Psychiatry 1998;59:585-588. View Abstract

Kuperberg GR, McGuire PK, David AS. Reduced sensitivity to linguistic context in schizophrenic thought disorder: Evidence from online monitoring for words in linguistically-anomalous sentences. Journal of Abnormal Psychology. 1998; 107:423-434. View Abstract

Magharious W, Goff DC, Amico E. Relationship of gender and menstrual status to symptoms and medication side effects in patients with schizophrenia. Psychiatry Research 1998;77:159-166. View Abstract

Tsai G, Goff DC, Chang RW, Flood J, Baer L, Coyle JT. Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia. American Journal of Psychiatry 1998; 9:1207-1213. View Abstract

Evins AE, Amico ET, Shih V, Goff DC. Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics. Journal of Neural Transmission 1997;104:761-766. View Abstract

Cohen LG, Chessley S, Eugenio L,Flood JG, Fisch J, Goff DC. Erythromycin-induced clozapine toxic reaction. Archives of Internal Medicine 1996;156:675-677. View Abstract

Goff DC, Tsai G, Manoach D, Flood J, Coyle JT. D-Cycloserine added to clozapine in patients with schizophrenia. American Journal of Psychiatry 1996;153:1628-1630. View Abstract

Henderson DC, Goff DC. Risperidone as an adjunct to clozapine therapy in chronic schizophrenia. Journal of Clinical Psychiatry 1996; 57:395-398. View Abstract

Goff DC, Midha KK, Sarid-Segal O, Hubbard JW, Amico E. A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia. Psychopharmacology 1995; 117:417-423. View Abstract

Goff DC, Tsai G, Beal MF, Coyle J. Tardive dyskinesia and substrates of energy metabolism in cerebrospinal fluid. American Journal of Psychiatry 1995; 152:1730-1736. View Abstract

Goff DC, Tsai G, Manoach DS, Coyle J. A dose-finding trial of D-cycloserine added to neuroleptic for negative symptoms of schizophrenia. American Journal of Psychiatry 1995; 152:1213-1215. View Abstract

Goff DC, Amico E, Dreyfus D, Ciraulo D: A placebo-controlled trial of trihexyphenidyl in medication-free patients with schizophrenia. American Journal of Psychiatry 1994; 151:429-431. View Abstract

Henderson DC, Goff DC. Clozapine for hyponatremia in schizophrenia. Biological Psychiatry 1994; 36:768-770. View Abstract

McCarthy MK, Goff DC, Baer L, Cioffi J, Herzog DB. Dissociation, childhood trauma, and the response to fluoxetine in bulimic patients. International Journal of Eating Disorders 1994; 15: 219-226. View Abstract

Goff DC, Renshaw P, Siegal OC, Dreyfus DA, Ciraulo D: A placebo-controlled trial of selegiline for tardive dyskinesia. Biological Psychiatry 1993;33:700-706. View Abstract

Goff DC, Simms C. Has multiple personality disorder remained consistent over time? A comparison of past and recent cases. Journal of Nervous and Mental Disorders 1993; 181:595-600. View Abstract

Goff DC, Henderson DC, Amico E. Cigarette smoking in schizophrenia: Relationship to psychopathology and medication side effects. American Journal of Psychiatry 1992; 149:1189-1194. View Abstract

Goff DC, Olin JA, Jenike MA, Baer L, Buttolph ML. Dissociative symptoms in patients with obsessive-compulsive disorder. Journal of Nervous and Mental Disorders 1992; 180:332-337. View Abstract

Pies R, Renshaw P, Goff DC, Metz A, Bachovchin W, Hotz R, Harmatz JS, Shader RI. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma from schizophrenics and normal controls. Research Communications in Psychology, Psychiatry and Behavior 1992; 17:25-31.

Goff DC, Arana GW, Greenblatt DJ, Dupont R, Ornsteen M, Harmatz JS, Shader RI. The effect of benztropine on haloperidol-induced dystonia, clinical efficacy and pharmacokinetics: A prospective, double-blind trial. Journal of Clinical Psychopharmacology 1991; 11:106-112. View Abstract

Goff DC, Brotman AW, Kindlon D, Waites M, Amico E. The delusion of possession in chronically-psychotic patients. Journal of Nervous and Mental Disorders 1991; 179:567-571. View Abstract

Goff DC, Brotman AW, Kindlon D, Waites M, Amico E. Self-reports of childhood abuse in chronically psychotic patients. Psychiatry Research 1991; 37:73-80. View Abstract

Goff DC, Brotman AW, McCormick S, Waites S, Amico E. Addition of fluoxetine elevates plasma haloperidol levels. American Journal of Psychiatry 1991; 148:790-792. View Abstract

Goff DC, Midha K, Brotman AW, McCormick S, Waites S, Amico E. An open trial of buspirone added to neuroleptics in schizophrenic patients. Journal of Clinical Psychopharmacology 1991; 11:193-197. View Abstract

Goff DC, Brotman AW, Waites M, McCormick M. Trial of fluoxetine added to neuroleptic in treatment-resistant schizophrenic patients. American Journal of Psychiatry 1990; 147:492-494. View Abstract

Jenike MA, Albert MS, Heller H, Gunther J, Goff D. Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer’s type: a double-blind placebo-controlled trial. Journal of Clinical Psychiatry 1990; 51:3-7. View Abstract

Arana GW, Goff DC, Baldessarini RJ, Keepers GA. Efficacy of anticholinergic prophylaxis for neuroleptic-induced acute dystonia. American Journal of Psychiatry 1988; 145:993-996. View Abstract

Metz A, Sichel DA, Goff DC. Postpartum panic disorder. Journal of Clinical Psychiatry 1988; 49:278-279. View Abstract

Jenike MA, Baer L, Brotman AW, Goff DC, Minichiello WE, Regan NJ. Obsessive compulsive disorder and the dexamethasone suppression test. Journal of Clinical Psychopharmacology 1987; 7:182-184. View Abstract

Jenike MA, Vitagliano HL, Baer L, Goff DC. Bowel obsessions: A variant of obsessive compulsive disorder responsive to antidepressants. American Journal of Psychiatry 1987; 144:1347-1348. View Abstract

Arana GW, Goff DC, Friedman H, Orensteen M, Greenblatt D, Black B, Shader RI. Does carbamazepine-induced lowering of haloperidol plasma levels worsen psychotic symptoms? American Journal of Psychiatry 1986; 143:650-651. View Abstract

Goff DC. Two cases of hypomania following the addition of l-tryptophan to a monamine oxidase inhibitor. American Journal of Psychiatry 1985; 142:1487-1488. View Abstract

Goff DC, Garber JH, Jenike MA. Partial resolution of ranitidine-associated delirium with. Ranitidine-associated delirium with physostigmine: A case report. Journal of Clinical Psychiatry 1985;46:400-401. View Abstract

Top of Page



		Schizophrenia Home \| MGH Home \| Privacy \| Disclaimer \| Contact Us


		© Copyright 2006 Massachusetts General Hospital. All rights reserved.